Sclerosis II-49
Rituxan(R) Gets FDA Approval for Use in RA II-49
Humira(R) Obtains FDA Approval for Treating AS II-49
Betaseron(R) Receives FDA Approval for Use in First Clinical
Episode of MS II-50
Abbott Receives FDA Clearance for HUMIRA Pen II-50
Remicade Obtains FDA Approval for Treating Pediatric Crohn`s
Disease II-50
6. RECENT INDUSTRY ACTIVITY II-52
Novo Nordisk and VLST Collaborate on Therapeutic Targets
Development II-52
Actemra's Approval Gets Delayed II-52
Apitope Raises Financing for Developing Multiple Sclerosis
Compound II-53
CalciMedica to Acquire Rights to STIM1 from TorreyPines II-53
Roche Acquires ARIUS Research, Inc. II-54
Astellas Inks Agreement with Maxygen for MAXY-4 Candidates II-54
Carna and Caliper Life Sciences Ink Collaborative Supply
Agreement II-55
Isotechnika Gets Back Worldwide Rights to Transplant Drug,
Voclosporin II-55
Boehringer In-licenses Two Drug Targets from BioFocus II-56
Bionomics Enters into a Development and Licensing Agreement
with Merck Serono II-56
Nycomed Inks Agreement with Immunomedics for Veltuzumab II-57
EpiVax Receives Grants from National Institutes of Health to
Advance Epi-13 II-57
Boehringer to Takeover Actimis II-58
Antisoma Acquires Xanthus Pharmaceuticals II-58
Merrimack Acquires Funds for Developing Cancer and Autoimmune
Disease Biologics II-59
BioSeek and Merck Sign Collaboration Agreement for Compound
Evaluation II-59
Questcor Amends Distribution Contract with US Distributor of
Acthar II-59
ANP Completes Phase Iia Trial for Multiple Sclerosis Drug II-60
Insert and Calando Merge to Form Calando Pharmaceuticals II-60
Codon Inks Research & Development and Licensing Deal with
Me
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |